BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21567388)

  • 1. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
    Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
    Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.
    Ye YW; Zhang X; Zhou Y; Wu J; Zhao C; Yuan L; Wang G; Du C; Wang C; Shi Y
    J Surg Oncol; 2012 Dec; 106(7):872-9. PubMed ID: 22585711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox17 regulates proliferation and cell cycle during gastric cancer progression.
    Ye YW; Wu JH; Wang CM; Zhou Y; Du CY; Zheng BQ; Cao X; Zhou XY; Sun MH; Shi YQ
    Cancer Lett; 2011 Aug; 307(2):124-31. PubMed ID: 21514720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
    Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q
    Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
    Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
    Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
    J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation.
    Roidl A; Berger HJ; Kumar S; Bange J; Knyazev P; Ullrich A
    Clin Cancer Res; 2009 Mar; 15(6):2058-66. PubMed ID: 19240166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
    Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
    Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
    Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q
    Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for Cdkl1 in the development of gastric cancer.
    Sun W; Yao L; Jiang B; Shao H; Zhao Y; Wang Q
    Acta Oncol; 2012 Jul; 51(6):790-6. PubMed ID: 22369697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.
    Wang YW; Qu Y; Li JF; Chen XH; Liu BY; Gu QL; Zhu ZG
    Clin Cancer Res; 2006 Aug; 12(16):4965-73. PubMed ID: 16914586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
    Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
    Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.